Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer.

Griguolo, G; Serna, G; Pascual, T; Fasani, R; Guardia, X; Chic, N; Paré, L; Pernas, S; Muñoz, M; Oliveira, M; Vidal, M; Llombart-Cussac, A; Cortés, J; Galván, P; Bermejo, B; Martínez, N; López, R; Morales, S; Garau, I; Manso, L; Alarcón, J; Martínez, E; Villagrasa, P; Prat, A; Nuciforo, P

Griguolo, G; Serna, G; Pascual, T; Fasani, R; Guardia, X; Chic, N; Paré, L; Pernas, S; Muñoz, M; Oliveira, M; Vidal, M; Llombart-Cussac, A; Cortés, J; Galván, P; Bermejo, B; Martínez, N; López, R; Morales, S; Garau, I; Manso, L; Alarcón, J; Martínez, E; Villagrasa, P; Prat, A; Nuciforo, P.

Afiliación

Griguolo G; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
Serna G; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy.
Pascual T; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Fasani R; Molecular oncology group, Vall d´Hebron Institute of Oncology, Barcelona, Spain.
Guardia X; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Chic N; Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain.
Paré L; SOLTI Breast Cancer Research Group, Barcelona, Spain.
Pernas S; Molecular oncology group, Vall d´Hebron Institute of Oncology, Barcelona, Spain.
Muñoz M; Molecular oncology group, Vall d´Hebron Institute of Oncology, Barcelona, Spain.
Oliveira M; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Vidal M; Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain.
Llombart-Cussac A; SOLTI Breast Cancer Research Group, Barcelona, Spain.
Cortés J; Institut Catala d'Oncologia-H.U.Bellvitge-IDIBELL, Hospitalet, Barcelona, Spain.
Galván P; Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain.
Bermejo B; Medical Oncology Department, Vall d'Hebrón University Hospital, Barcelona, Spain.
Martínez N; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
López R; Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain.
Morales S; Hospital Universitario Arnau de Vilanova de Valencia, Valencia, Spain.
Garau I; IOB Institute of Oncology, Quironsalud Group, Madrid & Barcelona, Spain.
Manso L; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Alarcón J; Hospital Clínico Universitario de Valencia/INCLIVA/CIBERONC, Valencia, Spain.
Martínez E; Hospital Universitario Ramón y Cajal, Madrid, Spain.
Villagrasa P; Hospital Clínico Universitario de Santiago, IDIS, CIBERONC, Santiago de Compostela, Spain.
Prat A; Hospital Universitario Arnau de Vilanova de Lleida, Lleida, Spain.
Nuciforo P; Hospital Son Llàtzer, Palma de Mallorca, Spain.

NPJ Precis Oncol ; 5(1): 23, 2021 Mar 19.

Article en En | MEDLINE | ID: mdl-33742063

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2021 Tipo del documento: Article